Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs national health care system (vol 151, pg 457, 2016)

Ioannou G. N.; Beste L. A.; Chang M. F.

首页> 外文期刊>Gastroenterology >Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs national health care system (vol 151, pg 457, 2016)

【24h】

Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs national health care system (vol 151, pg 457, 2016)

机译：Sofosbuvir，ledipasvir / sofosbuvir或paritaprevir / ritonavir / ombitasvir和dasabuvir方案在退伍军人事务国家卫生保健系统中治疗丙型肝炎的有效性（第151卷，第457页，2016年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Gastroenterology》 |2016年第6期|共1页
作者
Ioannou G. N.; Beste L. A.; Chang M. F.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs national health care system (vol 151, pg 457, 2016) [J] . Ioannou G. N., Beste L. A., Chang M. F. Gastroenterology . 2016,第6期

机译：Sofosbuvir，ledipasvir / sofosbuvir或paritaprevir / ritonavir / ombitasvir和dasabuvir方案在退伍军人事务国家卫生保健系统中治疗丙型肝炎的有效性（第151卷，第457页，2016年）
2. Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System [J] . Ioannou George N., Beste Lauren A., Chang Michael F., Gastroenterology . 2016,第3期

机译：Sofosbuvir，Ledipasvir / Sofosbuvir或Paritaprevir / Ritonavir / Ombitasvir和Dasabuvir方案在退伍军人事务国家卫生保健系统中治疗丙型肝炎患者的有效性
3. Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir and Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir-Based Antiviral Regimens for Hepatitis C in 17,847 patients in the Veterans Affairs National Healthcare System [J] . Ioannou George N., Beste Lauren A., Chang Michael, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：Sofosbuvir，Leadipasvir / Sofosbuvir和ParitaTavir / Ritonavir / Iombitasvir和Dasbuvir基于丙型肝炎的抗病毒方案在17,847名患者中的丙型肝炎患者中的丙肝炎患者的有效性
4. Effectiveness of Sofosbuvir Ledipasvir/Sofosbuvir or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System [O] . George N. Ioannou, Lauren A. Beste, Michael F. Chang, -1

机译：SofosbuvirLedipasvir / Sofosbuvir或Paritaprevir / Ritonavir / Ombitasvir和Dasabuvir方案在退伍军人事务国家卫生保健系统中治疗丙型肝炎的有效性
5. PGI21 Cost-effectiveness of treating Hepatitis C Virus (HCV) Genotype 1 (GT1) patients with abbvie 3D (Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir) +/- ribavirin compared to harvoni (Sofosbuvir/Ledipasvir) in the United States [O] . Johnson S., Parise H., Virabhak S., 2015

机译：PGI21与美国的harvoni（Sofosbuvir / Ledipasvir）相比，用abbvie 3D（Paritaprevir / Ritonavir / Ombitasvir和Dasabuvir）+/-利巴韦林治疗丙型肝炎病毒（HCV）基因1型（GT1）患者的成本效益

Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs national health care system (vol 151, pg 457, 2016)

著录项

相似文献

相关主题

期刊订阅